We are live on ! Find out more
OGEN icon

Oragenics

13 hedge funds and large institutions have $62.2K invested in Oragenics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1313 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.01% less ownership

Funds ownership: 0.08%0.06% (-0.01%)

54% less capital invested

Capital invested by funds: $136K → $62.2K (-$73.4K)

Holders
13
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q3 2024 in Review

13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2024, worth a combined $62.2K — down 54% from $136K a quarter earlier.

Fund positioning in OGEN was balanced in Q3 2024: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 0 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $26.3K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $23.4K sold.

  • 13 institutional investors held Oragenics (OGEN) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $62.2K of Oragenics stock for Q3 2024, down 54% quarter-over-quarter.
  • 4 funds opened new Oragenics positions in Q3 2024 and 4 closed out, a net change of 0 holders.
  • The largest Oragenics buyer in Q3 2024 was HRT Financial, an estimated $26.3K added.
  • The largest Oragenics seller in Q3 2024 was Renaissance Technologies, an estimated $23.4K sold.

Based on aggregated 13F filings for Q3 2024.